Sinopharm (company)

China National Pharmaceutical Group Corporation
	Headquarters
Trade name	Sinopharm
Company type	State-owned enterprise
Industry	Pharmaceutical; Biotechnology;
Founded	November 26, 1998
Headquarters	20 Zhichun Road, Haidian District, Beijing, China
Area served	China, exported worldwide
Key people	Liu Jingzhen (chairman & Chinese Communist Party Committee Secretary)
Products	Pharmaceutical drugs; vaccines;
Revenue	CN¥247.110 billion (2014)
Operating income	CN¥8.758 billion (2014)
Net income	CN¥2.705 billion (2014)
Total assets	CN¥199.192 billion (2014)
Total equity	CN¥31.944 billion (2014)
Owner	Chinese central government (100%)
Parent	SASAC of the State Council
Subsidiaries	Sinopharm Industrial Investment (51%); → Sinopharm Group (56.79%); Trad. Chinese Medicine (37.59%); Shyndec Pharma. (41.62%); China National Biotec Group (95%); → Tiantan Biological (53.30%);
Chinese name
Simplified Chinese	中国医药集团总公司
Traditional Chinese	中國醫藥集團總公司
Hanyu Pinyin
Transcriptions
Standard Mandarin
Hanyu Pinyin	Zhōngguó yīyào jítuán zǒng gōngsī
short Chinese name
Simplified Chinese	国药集团
Traditional Chinese	國藥集團
Hanyu Pinyin
Transcriptions
Standard Mandarin
Hanyu Pinyin	Guóyào jítuán
	Footnotes / references; in a consolidated basis; equity and profit excluded minority interests; in Chinese Accounting Standards

China National Pharmaceutical Group Corporation (CNPGC), commonly referred to as Sinopharm, is a Chinese state-owned enterprise. The corporation was the indirect major shareholder of publicly traded companies Sinopharm Group (SEHK: 1099, via a 51–49 joint venture, Sinopharm Industrial Investment, with Fosun Pharmaceutical), China Traditional Chinese Medicine [zh] (SEHK: 570, mostly via Sinopharm Group Hongkong Co., Ltd.),^[4] Shanghai Shyndec Pharmaceutical (SSE: 600420, via a wholly owned research institute based in Shanghai), and Beijing Tiantan Biological Products (SSE: 600161, via China National Biotec Group).

Sinopharm was ranked 109th in the 2021 Fortune Global 500 list.^[6]

^ "中国医药集团有限公司主要领导调整" (in Chinese). Sinopharm. Archived from the original on 2022-09-08. Retrieved 2021-08-24.
^ "Liu Jingzhen". Bloomberg.
^ "中国医药集团总公司2016年度第一期超短期融资券发行披露材料" [Pospectus of 2016 (batch 1) Ultra-short-term financing of Sinopharm]. Sinopharm (in Chinese). Shanghai Clearing House. 19 January 2016. Retrieved 22 November 2016.
^ "2015 Annual Report" (PDF). China Traditional Chinese Medicine. Hong Kong Stock Exchange. 28 April 2016. Retrieved 22 November 2016.
^ "央企名录 (List of Central SOEs)". Official website of SASAC (in Chinese). Retrieved 3 March 2016.
^ "Global 500".